Citation 5526

MORI-HONGO,M: TAKIMOTO,H: KATAGIRI,T: KIMURA,M: IKEDA,Y: MIYASE,T:. (2009). MELANIN SYNTHESIS INHIBITORS FROM LESPEDEZA FLORIBUNDA. 72(2)

Citation Details

Title	MELANIN SYNTHESIS INHIBITORS FROM LESPEDEZA FLORIBUNDA
Authors	MORI-HONGO,M: TAKIMOTO,H: KATAGIRI,T: KIMURA,M: IKEDA,Y: MIYASE,T:
Year	2009
Volume	72
Issue	2

Summary

Year: 2009

Journal: Unknown

Organisms and Their Experiments (1)

Lespedeza floribunda (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN A1	None
2	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN A1	ACTIVE
3	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN A2	None
4	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN A2	ACTIVE
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN A3	None
6	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN A3	ACTIVE
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN A4	None
8	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN A4	ACTIVE
9	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN B1	None
10	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN B1	ACTIVE
11	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN B2	None
12	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN B2	ACTIVE
13	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN B3	None
14	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN B3	ACTIVE
15	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN B4	None
16	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN B4	ACTIVE
17	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN C1	None
18	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN C1	INACTIVE
19	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN C2	None
20	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN C2	ACTIVE
21	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN C3	None
22	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN C3	None
23	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN C4	None
24	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN C4	INACTIVE
25	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN C5	None
26	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN C5	INACTIVE
27	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN C6	None
28	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN C6	ACTIVE
29	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN C7	None
30	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN C7	ACTIVE
31	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN D1	None
32	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN D1	ACTIVE
33	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN E1	None
34	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN E1	ACTIVE
35	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN F1	None
36	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN F1	ACTIVE
37	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN F2	None
38	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN F2	ACTIVE
39	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G1	None
40	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G1	ACTIVE
41	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G2	None
42	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G2	ACTIVE
43	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G3	None
44	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G3	ACTIVE
45	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G4	None
46	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G4	ACTIVE
47	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G5	None
48	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G5	ACTIVE
49	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G6	None
50	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G6	ACTIVE
51	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G7	None
52	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G7	ACTIVE
53	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G8	None
54	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G8	ACTIVE
55	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G9	None
56	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G9	ACTIVE
57	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G10	None
58	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G10	ACTIVE
59	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G11	None
60	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G11	ACTIVE
61	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN G12	None
62	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN G12	ACTIVE
63	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN H1	None
64	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN H1	ACTIVE
65	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN H2	None
66	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN H2	ACTIVE
67	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN I1	None
68	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN I1	ACTIVE
69	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN I2	None
70	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN I2	ACTIVE
71	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN I3	None
72	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN I3	ACTIVE
73	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN J1	None
74	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN J1	ACTIVE
75	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN J2	None
76	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN J2	INACTIVE
77	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	None	None
78	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN J3	ACTIVE
79	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	LESPEFLORIN J3LESPEFLORIN J4	None
80	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LESPEFLORIN J4	INACTIVE
81	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	BAVACHIN	None
82	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BAVACHIN	ACTIVE
83	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	PROSTRATOL	None
84	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PROSTRATOL	ACTIVE
85	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	EUCHRENONE A-3	None
86	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	EUCHRENONE A-3	ACTIVE
87	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CAJAFLAVANONE	None
88	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAJAFLAVANONE	ACTIVE
89	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	GENISTEIN	None
90	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GENISTEIN	ACTIVE
91	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	ERYTHRABYSSIN II	None
92	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERYTHRABYSSIN II	ACTIVE
93	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	ERYBRAEDIN A	None
94	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERYBRAEDIN A	ACTIVE
95	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	ERYBRAEDIN B	None
96	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ERYBRAEDIN B	ACTIVE
97	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	FOLITENOL	None
98	MELANIN FORMATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FOLITENOL	ACTIVE

Citation 5526

Citation Details

Summary

Organisms and Their Experiments (1)

Lespedeza floribunda (FABACEAE)

Show SPARQL Queries (1)

Query 1